NexGen Health in San Jose has launched a physician-led Cerebrolysin IV Therapy Program, offering advanced neurological support through a personalized 10-treatment protocol.
Designed to aid patients with stroke, traumatic brain injury, cognitive decline, and neurodegenerative diseases, this science-backed therapy enhances neuroplasticity, reduces inflammation, and supports long-term brain health.
SAN JOSE, Calif., Sept. 11, 2025 /PRNewswire/ — NexGen Health, a physician-led regenerative and functional medicine clinic based in San Jose, has announced the official launch of its exclusive Cerebrolysin IV Therapy Program—a cutting-edge neurorecovery protocol designed to support brain health, enhance cognitive function, and provide personalized care for patients managing complex neurological conditions.
Led by board-certified physicians specializing in regenerative medicine, physical medicine, interventional pain, and functional medicine, NexGen Health’s Cerebrolysin program is centered around a personalized 10-treatment intravenous protocol. Patients are carefully evaluated and monitored throughout the process, which is designed to support recovery from stroke, traumatic brain injury, cognitive decline, and neurodegenerative diseases such as Alzheimer’s and Parkinson’s.
“We are thrilled to bring this groundbreaking neurorecovery therapy to Silicon Valley. This treatment has been so transformative and has worked miracles in the lives of our patients”, said Ilbra Petros, Director of Nexgen Health. “Cerebrolysin represents a significant advancement in our ability to support patients with neurological conditions. This therapy offers new possibilities for those seeking to optimize brain health, enhance cognitive function, and recover from injuries where traditional treatments may have shown limited efficacy.”
Cerebrolysin is a neuropeptide-based therapy containing small proteins and amino acids that mimic naturally occurring neurotrophic factors—the compounds that support neuron growth and survival. Unlike many therapies, Cerebrolysin is capable of crossing the blood-brain barrier, enabling direct access to brain tissue. Its clinical effects include stimulation of neuroplasticity, reduction of neuroinflammation, improved synaptic function, and protection against oxidative stress.
Each treatment begins with medical clearance through NexGen Health’s clinical team. Once approved, patients receive daily or alternate-day IV infusions of Cerebrolysin over a 10-day period, with treatment sessions typically lasting 20 to 45 minutes. The peptides are rapidly absorbed and transported to brain tissue, where they deliver neuroprotective and regenerative effects through a variety of scientifically validated pathways.
The protocol is tailored to patient-specific goals and may be repeated or adjusted based on progress. Many patients report encouraging outcomes within the first cycle, with ongoing improvements in cognitive clarity, focus, motor function, and neurologic resilience.
“What sets our Cerebrolysin program apart is our comprehensive, physician-supervised approach,” said Dr. James Petros, Founder of NexGen Health. “We take the time to evaluate each patient’s unique needs, customize the dosage, and monitor treatment closely. Our goal is to offer safe, science-backed solutions that restore function and improve quality of life.”
With this launch, NexGen Health further strengthens its position as a leader in innovative biologic and regenerative treatments. The clinic recently introduced Niagen Plus IV Therapy and celebrated a major milestone of 150 five-star Google reviews, underscoring its reputation for patient satisfaction, safety, and results-driven care.
Located in the heart of Silicon Valley, NexGen Health provides a wide range of physician-developed programs for neurologic, metabolic, and cellular health—serving patients in San Jose, Los Gatos, Cupertino, and beyond.
About NexGen Health
Founded by Dr. James Petros in 2021, NexGen Health is a physician-led clinic specializing in functional medicine, regenerative therapies, IV nutrient therapy, hormone optimization, peptide treatments, and advanced wellness programs. The medical team is board-certified in interventional pain and rehabilitation, physical medicine, anti-aging, and longevity care. NexGen Health combines scientific validation, precision diagnostics, and customized protocols to help patients reach their highest level of wellness.
To learn more about the Cerebrolysin IV Therapy Program or to schedule a consultation, visit www.MyNexGenHealth.com or call (408) 400-2967.
Medical clearance through NexGen Health’s medical team is required to begin treatment.
Media Contact:
Ilbra Petros
Director, NexGen Health
Phone: (408) 400-2967
Website: www.MyNexGenHealth.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/cerebrolysin-iv-therapy-now-available-at-nexgen-health-in-silicon-valley-302553961.html
SOURCE NexGen Health
